| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 668674 | 72063 | OLIMEL N7E EMULSION PARA PERFUSION | OLIMEL N7E EMULSION PARA PERFUSION , 4 bolsas de 2.000 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 2.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72063/72063_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72063/72063_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2014-04-23 | View Edit Delete | ||||||||||||
| 668678 | 72065 | OLIMEL N9E EMULSION PARA PERFUSION | OLIMEL N9E EMULSION PARA PERFUSION , 6 bolsas de 1.000 ml | N/A (más de 4 PA) | 3 | 6 | 65 | 6 bolsas de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72065/72065_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72065/72065_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2010-06-02 | 1 | 1 | 1 | 2010-06-02 | 2010-06-02 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 668679 | 72065 | OLIMEL N9E EMULSION PARA PERFUSION | OLIMEL N9E EMULSION PARA PERFUSION , 4 bolsas de 1.500 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 1.500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72065/72065_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72065/72065_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2010-06-02 | 1 | 1 | 1 | 2010-06-02 | 2010-06-02 | 1 | 2019-06-18 | View Edit Delete | ||||||||||||
| 668680 | 72065 | OLIMEL N9E EMULSION PARA PERFUSION | OLIMEL N9E EMULSION PARA PERFUSION , 4 bolsas de 2.000 ml | N/A (más de 4 PA) | 3 | 4 | 65 | 4 bolsas de 2.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72065/72065_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72065/72065_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2010-06-02 | 1 | 1 | 1 | 2010-06-02 | 2010-06-02 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 668682 | 72066 | OLIMEL N9 EMULSION PARA PERFUSION | OLIMEL N9 EMULSION PARA PERFUSION, 6 bolsas de 1.000 ml | N/A (más de 4 PA) | 3 | 6 | 65 | 6 bolsas de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72066/72066_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72066/72066_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 7980 | BAXTER S.L. | 2010-06-02 | 1 | 1 | 1 | 2010-06-02 | 2010-06-02 | 1 | 2011-03-08 | View Edit Delete | ||||||||||||
| 665534 | 72440 | ATORVASTATINA VIR PHARMA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72440/72440_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72440/72440_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665535 | 72441 | ATORVASTATINA VIR PHARMA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72441/72441_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72441/72441_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665536 | 72442 | ATORVASTATINA VIR PHARMA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72442/72442_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72442/72442_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 665537 | 72443 | ATORVASTATINA VIR PHARMA 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA VIR PHARMA 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72443/72443_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72443/72443_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2010-06-22 | 1 | 1 | 1 | 2010-06-22 | 2010-06-22 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 667304 | 71957 | ANASTROZOL VIR 1 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ANASTROZOL VIR 1 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 28 comprimidos | 1 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71957/71957_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71957/71957_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2012-05-22 | 1 | 1 | 1 | 2012-05-22 | 2012-05-22 | 1 | 2013-11-14 | View Edit Delete | ||||||||||||
| 668434 | 63564 | SEROPRAM 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SEROPRAM 30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 30 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63564/63564_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63564/63564_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1710 | LUNDBECK ESPANA S.A. | 2001-01-05 | 1 | 1 | 1 | 2001-01-05 | 2001-01-05 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 670380 | 61586 | SERDOLECT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61586/61586_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61586/61586_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 670398 | 61585 | SERDOLECT 16 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 16 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 16 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61585/61585_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61585/61585_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 670406 | 61584 | SERDOLECT 12 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 12 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 28 comprimidos | 12 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61584/61584_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61584/61584_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 670422 | 61582 | SERDOLECT 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | SERDOLECT 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 30 comprimidos | 4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61582/61582_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61582/61582_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | LUNDBECK ESPANA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665782 | 10612002 | REVOLADE 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | REVOLADE 25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10612002/10612002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10612002/10612002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665783 | 10612005 | REVOLADE 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | REVOLADE 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 28 comprimidos | 50 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/10612005/10612005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/10612005/10612005_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2010-04-09 | 1 | 1 | 1 | 2010-04-09 | 2010-04-09 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 665944 | 07422006 | TASIGNA 150 MG CAPSULAS DURAS | TASIGNA 150 MG CAPSULAS DURAS, 112 cápsulas | 150 mg | 5 | 112 | 43 | 112 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07422006/07422006_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07422006/07422006_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 28642 | NOVARTIS FARMACEUTICA S.A. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-07-07 | View Edit Delete | ||||||||||||
| 669622 | 61628 | FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | FEMARA 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 30 comprimidos | 2,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61628/61628_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61628/61628_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1945 | NOVARTIS FARMACEUTICA S.A. | 1997-09-01 | 1 | 1 | 1 | 1997-09-01 | 1997-09-01 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 668027 | 72028 | DROSURELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | DROSURELLE 0.02 mg/3 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 21 comprimidos | 3 mg/0,02 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72028/72028_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72028/72028_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7216 | LABORATORIOS EFFIK S.A. | 2011-03-25 | 1 | 1 | 1 | 2011-03-25 | 2011-03-25 | 1 | 2011-10-27 | View Edit Delete |
Page 226 of 1035, showing 20 records out of 20697 total, starting on record 4501, ending on 4520